Newsroom

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 1/8/2026 Issue ¦ Gracechurch Card Programme Funding Plc - Series 15-1 Class A GBP 1,500,000,000 FRN due November 2023     ISIN Number ¦ XS1321880418 ISIN Reference ¦ 132188041 Issue Nomin GBP ¦ 1500000000 Period ¦ 12/15/2025 to 1/15/2026   Payment Date 1/15/2026 Number of Days ¦ 31 Rate ¦ 4.5435   Denomination GBP ¦ 1000   ¦ 1500000000   ¦       Amount Payable per Denomination ¦ 3.86   ¦ 5788294.52...

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 1/8/2026 Issue ¦ Gracechurch Card Programme Funding PLC - Series 14 - 2 Class A GBP 1,600,000,000 FRN due June 2024     ISIN Number ¦ XS1133034923 ISIN Reference ¦ 113303492 Issue Nomin GBP ¦ 1600000000 Period ¦ 12/15/2025 to 1/15/2026   Payment Date 1/15/2026 Number of Days ¦ 31 Rate ¦ 4.3435   Denomination GBP ¦ 1000   ¦ 1600000000   ¦       Amount Payable per Denomination ¦ 3.69   ¦ 5902400   ¦  ...

LAS VEGAS--(BUSINESS WIRE)--Xanterra Travel Collection® and T-Mobile Arena Announce New Multi-Year Partnership Putting the Spotlight On The Oasis at Death Valley...

AUSTIN, Texas--(BUSINESS WIRE)--Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases, today announced positive topline results from its randomized, head-to-head Phase 1b JADE clinical study comparing OLN324, a next-generation VEGF/Ang2 bispecific antibody, to faricimab (Vabysmo®), in over 160 patients with diabetic macular edema (DME) or wet (neovascular) age-related macular degeneration (wAMD). OLN324’s up to 60-fold high...

DALLAS & LYON, France--(BUSINESS WIRE)--Regulatory News: SMAIO (Software, Machines and Adaptive Implants in Orthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker: ALSMA), a French-American player specialized in complex spine surgery, offering an integrated pre, intra, and post-operative solution based on a 3D planning software, adaptive implants and related services, today announces its indicative financial calendar for 2026. Events Dates 2025 full-year revenue Tuesday, January 20,...

SEATTLE--(BUSINESS WIRE)--HoX announces a pilot with Lawrence Livermore National Laboratory, backed by the Department of War, to build a next-generation biosecurity platform....

DIJON, France & STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN : FR001400CM63 ; Mnémonique : ALOPM), entreprise biopharmaceutique spécialisée en médecine de précision pour le traitement des cancers résistants et métastatiques, et Ksilink, leader en criblage phénotypique à haut débit de systèmes cellulaires dérivés de patients, méthode permettant d’analyser directement des cellules issues de patients pour identifier de nouvelles cibles ou thérapie...

PARIS--(BUSINESS WIRE)--Regulatory News: Verallia (Paris:VRLA) announces that the Italian Competition Authority (AGCM) has decided to close without further action the investigation launched in 2023 concerning several glass manufacturers, including Verallia Italia, regarding price increases since 2022 in the wine bottle sector. No infringement was found. This decision confirms that the price increases observed in 2022 reflected an extraordinary cost environment (energy and raw materials) and str...

AUSTIN, Texas--(BUSINESS WIRE)--Upshop, a leader in connected store solutions for food retail, announced an integration with Toast, the digital platform built for hospitality...

PARIS & LONDON & NEW YORK--(BUSINESS WIRE)--Regulatory News: In accordance with the provisions of the French Financial Markets Authority’s decision N°2021-01 of 22 June 2021 renewing the implementation of liquidity contracts for shares as an accepted market practice, Antin (Paris:ANTIN) informs the public of the following: - Available resources on 31 December 2025: 92,048 Antin shares and €221,347 - Number of transactions on buy side in the second half of 2025: 2,329 - Number of transactions on...